These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1116 related items for PubMed ID: 18348166

  • 1. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D.
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [Abstract] [Full Text] [Related]

  • 2. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K, Sakamuro D, Basu A, Du W, Wunner W, Staller P, Gaubatz S, Zhang H, Prochownik E, Eilers M, Prendergast GC.
    Oncogene; 1999 Jun 17; 18(24):3564-73. PubMed ID: 10380878
    [Abstract] [Full Text] [Related]

  • 3. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL, Rand A, Kelm RJ, Getz MJ.
    Oncogene; 2000 Jul 13; 19(30):3352-62. PubMed ID: 10918592
    [Abstract] [Full Text] [Related]

  • 4. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB, Du W, Donover S, Baker J, Liu AX, Sharp DM, Muller AJ, Prendergast GC.
    Oncogene; 2003 Jun 05; 22(23):3578-88. PubMed ID: 12789266
    [Abstract] [Full Text] [Related]

  • 5. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
    Elliott K, Ge K, Du W, Prendergast GC.
    Oncogene; 2000 Sep 28; 19(41):4669-84. PubMed ID: 11032017
    [Abstract] [Full Text] [Related]

  • 6. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL, Ryan P, Gorziglia M, Clarke L, Hawkins LK, Hay C, Huang Y, Kaloss M, Marinov A, Phipps S, Pinkstaff A, Shirley P, Skripchenko Y, Stewart D, Forry-Schaudies S, Hallenbeck PL.
    Cancer Res; 2003 Apr 01; 63(7):1490-9. PubMed ID: 12670895
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. p27kip1-independent cell cycle regulation by MYC.
    Berns K, Martins C, Dannenberg JH, Berns A, te Riele H, Bernards R.
    Oncogene; 2000 Oct 05; 19(42):4822-7. PubMed ID: 11039898
    [Abstract] [Full Text] [Related]

  • 9. The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage.
    Cassimere EK, Pyndiah S, Sakamuro D.
    Cell Death Differ; 2009 Dec 05; 16(12):1641-53. PubMed ID: 19629135
    [Abstract] [Full Text] [Related]

  • 10. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
    Deng Q, Li Y, Tedesco D, Liao R, Fuhrmann G, Sun P.
    Cancer Res; 2005 Sep 15; 65(18):8298-307. PubMed ID: 16166306
    [Abstract] [Full Text] [Related]

  • 11. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
    Alevizopoulos K, Sanchez B, Amati B.
    Oncogene; 2000 Apr 13; 19(16):2067-74. PubMed ID: 10803468
    [Abstract] [Full Text] [Related]

  • 12. Recruitment of TRRAP required for oncogenic transformation by E1A.
    Deleu L, Shellard S, Alevizopoulos K, Amati B, Land H.
    Oncogene; 2001 Dec 13; 20(57):8270-5. PubMed ID: 11781841
    [Abstract] [Full Text] [Related]

  • 13. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C, Chen N, Sawadogo M.
    Exp Cell Res; 2005 Jan 01; 302(1):1-10. PubMed ID: 15541720
    [Abstract] [Full Text] [Related]

  • 14. Adenoviral E1A function through Myc.
    Chakraborty AA, Tansey WP.
    Cancer Res; 2009 Jan 01; 69(1):6-9. PubMed ID: 19117980
    [Abstract] [Full Text] [Related]

  • 15. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A, Buchholz M, Wagner M, Adler G, Gress T, Ellenrieder V.
    Mol Cancer Res; 2006 Nov 01; 4(11):861-72. PubMed ID: 17114344
    [Abstract] [Full Text] [Related]

  • 16. Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: repression of transcriptional activation by p53.
    Kannabiran C, Morris GF, Mathews MB.
    Oncogene; 1999 Dec 16; 18(54):7825-33. PubMed ID: 10618724
    [Abstract] [Full Text] [Related]

  • 17. Bin1 mediates apoptosis by c-Myc in transformed primary cells.
    DuHadaway JB, Sakamuro D, Ewert DL, Prendergast GC.
    Cancer Res; 2001 Apr 01; 61(7):3151-6. PubMed ID: 11306501
    [Abstract] [Full Text] [Related]

  • 18. TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis.
    Dugan KA, Wood MA, Cole MD.
    Oncogene; 2002 Aug 29; 21(38):5835-43. PubMed ID: 12185582
    [Abstract] [Full Text] [Related]

  • 19. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN, McCabe MT, Hayward SW, Park JM, Day ML.
    Cancer Res; 2005 May 01; 65(9):3633-42. PubMed ID: 15867358
    [Abstract] [Full Text] [Related]

  • 20. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
    Zhu CY, Li CY, Li Y, Zhan YQ, Li YH, Xu CW, Xu WX, Sun HB, Yang XM.
    Cell Death Differ; 2009 Mar 01; 16(3):395-405. PubMed ID: 19008924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.